# Suraksha Diagnostic Ltd (SURAKSHA)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹275.7
Day Change: +0.18%
52W High: ₹353.65
52W Low: ₹224.1
Market Cap: ₹1,594 Cr

## Valuation
P/E: 49.04
P/B: 6.9
EPS: ₹6.24
Book Value: ₹44.35
Dividend Yield: 0%

## Returns
1Y Return: -7.92%

## Profitability
ROE: 0%
ROCE: 19.76%
Debt/Equity: 0.51
Revenue Growth: 29.2%
Profit Growth: 22%
EBITDA Margin: 15.62%
Operating Margin: 17.32%

## About
Suraksha Diagnostic Ltd is a Diagnostics & Research company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Diagnostics & Research
Sub Industry: Unknown

## Business Model
Overview: Suraksha Diagnostic Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- Quarterly Report: Board Meeting Intimation for Inter-Alia, Considering And Approving Audited (Standalone And Consolidated) Financial Results Of The Company For Quarter And FY 2025-26 And To Consider Recommendation Of Dividend, If Any, On Equity Shares Of Company For FY 2025-26.
- BSE Filing: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

## Access
Current tier: anonymous
More history: Register free to see 3 more years.

## Data Freshness
Quote Updated: 2026-06-08T20:00:07.519Z
Price History Updated: 2026-06-09T02:01:38.187Z
Latest Price History Date: 2026-06-08
Technicals Updated: 2026-06-09T02:01:38.187Z
Quant Updated: 2026-06-09T02:01:38.187Z
Sentiment Updated: 2026-06-09T02:01:38.187Z
Financials Status: current
Financials Updated: 2026-05-18T17:32:03.344Z
Financials Last Attempt: 2026-05-18T17:32:03.344Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2021)
Revenue: ₹158 Cr
Operating Profit: ₹34 Cr (OPM 22%)
Net Profit: ₹15 Cr
Tax: ₹21 Cr

## Annual P&L History
Mar 2021: Rev ₹158Cr | PAT ₹15Cr | OPM 22%
Mar 2022: Rev ₹140Cr | PAT ₹6Cr | OPM 18%
Mar 2023: Rev ₹223Cr | PAT ₹24Cr | OPM 22%

## Balance Sheet (Mar 2021)
Total Assets: ₹173 Cr
Total Liabilities: ₹173 Cr
Borrowings: ₹13 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Somnath  Chatterjee, Executive Chairman & Joint MD
- Ritu  Mittal, Joint MD, CEO & Executive Director
- Ravindra K. S., Chief Financial Officer
- Mamta  Jain, Company Secretary & Compliance Officer
- Sangeeta  Chakraborty, General Manager of Operations

---
Source: rupiya.io/stocks/suraksha
Disclaimer: For research and education only. Not investment advice.